Memantine LEK
Land: Europeiska unionen
Språk: danska
Källa: EMA (European Medicines Agency)
Bipacksedel
(PIL)
16-11-2020
Produktens egenskaper
(SPC)
16-11-2020
Offentlig bedömningsrapport
(PAR)
29-04-2013
Aktiva substanser:
memantinhydrochlorid
Tillgänglig från:
Pharmathen S.A.
ATC-kod:
N06DX01
INN (International namn):
memantine
Terapeutisk grupp:
Psychoanaleptics, , Andre demensmedicin
Terapiområde:
Alzheimers sygdom
Terapeutiska indikationer:
Behandling af patienter med moderat til svær Alzheimers sygdom.
Produktsammanfattning:
Revision: 5
Bemyndigande status:
autoriseret
Tillstånd datum:
2013-04-21
Bipacksedel
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Läs hela dokumentet
Produktens egenskaper
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Läs hela dokumentet
